Perimeter Medical Imaging AI Inc (OTCPK:PYNKF)

Q1 2025 Perimeter Medical Imaging AI Inc Earnings Call Transcript

May 13, 2025 / 09:00 PM GMT

Release Date Price: $0.2803 (+0.14%)

Transcript

Key Points

Positve

Perimeter Medical Imaging AI Inc (PYNKF) reported a 460% increase in revenue for Q1 2025 compared to Q1 2024, indicating strong sales growth.
The company achieved multiple commercial milestones, including its first capital unit sale and record patient cases supported by the S Series OCT.
Perimeter's B Series OCT system, which combines AI technology with optical coherence tomography, showed promising results in a pivotal clinical trial, meeting its primary endpoint.
The FDA PMA submission for the B Series OCT represents a significant regulatory milestone, potentially paving the way for full commercial launch.
The company is expanding its market presence, with new installations in three additional states: New Mexico, Tennessee, and Arizona.

Negative

Perimeter Medical Imaging AI Inc (PYNKF) reported a net loss of $4.3 million for Q1 2025, an increase from the $2.1 million loss in Q1 2024.
Operating expenses remained high at $4.6 million for the first quarter, unchanged from the previous year.
The company has limited cash reserves, with cash and cash equivalents at $2.4 million as of March 31, 2025, necessitating additional capital to execute its growth strategy.
There is uncertainty regarding the timing of FDA approval for the B Series OCT, as the company awaits further feedback from the agency.
The company faces challenges in expanding its user base, as it relies on a small sales team and must navigate complex hospital procurement processes.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PINK.V - Perimeter Medical Imaging AI Inc
Q1 2025 Perimeter Medical Imaging AI Inc Earnings Call
May 13, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon ladies and gentlemen and welcome to the Perimeter Medical Q1 2025 conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call. You require immediate assistance, please press 0 for the operator. This call is being recorded on Tuesday, May 13, 2025. I would now like to turn the conference over to Mr. Stephen Kilmer of investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Good afternoon,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.